Biosyent Inc BIOYF

Share Buyback

[retiredcf]

Always a sign that the company feels that their stock is undervalued. GLTA

09:03 AM EST, 12/11/2020 (MT Newswires) -- The TSXV has accepted BioSyent's Notice of Intention to Make a Normal Course Issuer Bid, allowing the company to buy back up to 950,000 of its common shares over a 12-month period, approximately 7.42% of the shares outstanding.

The NCIB will commence on Dec 17 and terminate on Dec 16, 2021.

BioSyent has entered into an automatic share purchase plan with a broker, Raymond James, to allow for share purchases during certain pre-determined blackout periods.

Price: 6.92, Change: -0.08, Percent Change: -1.14

[lscfa]

Cash on balance sheet was bringing down ROE.

[overnout]

It will be interesting to see at what price we achieve equilibrium for the NCIB. At what price do the sellers appear and at what price does Biosyent still believe that buying back shares represents better value than what it is presently getting on cash or a capital investment other than it's own stock.

[overnout]

Nice. Should add a little zest to the stock price over time as it seems to have flatlined at $7 overnout